FDA Approvals

Date Posted
Article Title
9/5/2012
Bosulif Approved for Rare Leukemia

Primarily caused by genetic mutation

8/31/2012
Xtandi Approved for Advanced Prostate Cancer

Drug increased survival time for patients who'd failed hormone-based treatments

8/30/2012
Afinitor Disperz Approved for Rare Tumor

Sanctioned for children aged 1 and older

8/30/2012
New Drug Approved for Irritable Bowel, Chronic Constipation

Linzess sanctioned for cases that don't respond to conventional treatment

8/30/2012
New Drug Approved for Lack of Certain White Blood Cells

A condition affecting some chemotherapy patients

8/28/2012
Once-Daily Pill Approved to Treat HIV

Stribild, combination therapy, interferes with AIDS virus' ability to multiply

8/17/2012
FDA Approves Generic Versions of Actos

Diabetes drug helps control blood sugar in adults with type 2 disease

8/14/2012
Flu Season's Vaccine Approved

Two of three strains weren't in last season's vaccine

8/10/2012
Lucentis Approved for Diabetic Macular Edema

Leading cause of diabetic blindness

8/9/2012
Marqibo Approved for Rare Leukemia

Sanctioned as an orphan drug

8/3/2012
8/3/2012
Zaltrap Approved for Advanced Colorectal Cancer

Among people whose cancer has spread

7/24/2012
Tudorza Pressair Approved for COPD

Inhaler treats narrowed lung airways

7/20/2012
Afinitor Approved for Advanced Breast Cancer

Among certain postmenopausal women

7/20/2012
Kyprolis Approved for Multiple Myeloma

In people who have had other therapies

7/18/2012
Another New Weight-Loss Drug Approved

Qsymia sanctioned for obese or overweight people with chronic condition

7/17/2012
7/17/2012
First Drug Approved to Lower Risk of Acquiring HIV

Truvada sanctioned for uninfected adults at higher risk

7/9/2012
New Test Helps Evaluate Cancer Drug's Merit

Erbitux is designed for people with colon cancer

7/5/2012
Test Approved to Help Treat Common Infection in Transplant Patients

CMV preys on people with weaker immune systems